What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma

preview_player
Показать описание
What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients.

Follow the link in our bio to earn FREE AMA, ABS or ANCC credit!
Рекомендации по теме